(3.232.129.123) 您好!臺灣時間:2021/03/06 01:38
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:劉俊霆
研究生(外文):Chun-Ting Liu
論文名稱:薑精油抗酒精性脂肪肝之代謝體學研究
論文名稱(外文):Metabolomics Study of Ginger Essential Oil against Alcoholic Fatty Liver
指導教授:沈立言沈立言引用關係
口試委員:何其儻郭錦樺曾宇鳳邱義源謝淑貞
口試日期:2014-07-04
學位類別:博士
校院名稱:國立臺灣大學
系所名稱:食品科技研究所
學門:農業科學學門
學類:食品科學類
論文種類:學術論文
論文出版年:2014
畢業學年度:102
語文別:中文
論文頁數:112
中文關鍵詞:酒精性脂肪肝薑精油酒精液態飼料代謝體學生物標記物
外文關鍵詞:AFLDginger essential oilLieber-DeCarli dietmetabolomicsbiomarker
相關次數:
  • 被引用被引用:0
  • 點閱點閱:606
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
脂肪肝與肝硬化及肝癌有高度相關性,臨床上一般可分為非酒精性脂肪肝 (non-alcoholic fatty liver disease, NAFLD)及酒精性脂肪肝 (alcoholic fatty liver disease, AFLD)。非酒精性脂肪肝發生原因主要與代謝症候群如肥胖、胰島素阻抗等有關,造成肝臟中三酸甘油酯過度累積。此外,過量攝取酒精則會導致酒精性脂肪肝。已有研究證實,食用薑能夠增強肝臟中抗氧化系統及解毒系統功能,進而達到護肝功效。因此,本研究利用給予酒精液態飼料 (Lieber-DeCarli diet)誘導C57BL/6 (B6)小鼠脂肪肝之動物模式,實驗過程中以管灌餵食方式給予小鼠薑精油 (ginger essential oil, GEO)或檸檬醛 (citral),進行為期四週之動物試驗,探討薑精油保護肝臟之功效及機制,進一步以超高效能液相層析結合四極柱-飛行式質譜儀 (ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry, UHPLC-QTOF-MS)分析小鼠血清及尿液代謝物,進行代謝體學之探討。由實驗結果得知,小鼠食用酒精液態飼料四週即會生成脂肪肝;此外,由血液生化分析、肝臟抗氧化酵素分析及肝臟組織病理切片之結果可推測,管灌餵食GEO之小鼠,其酒精性脂肪肝生成情況具有顯著改善之效果。由酒精所誘導之脂肪肝小鼠,其血清及尿液中有數種代謝物可能是關鍵的生化代謝途徑物質,包括葡萄糖醛酸內酯 (D-glucurono-6,3-lactone)、甘油-3-磷酸鹽 (glycerol-3-phosphate)、丙酮酸 (pyruvic acid)、石膽酸 (lithocholic acid)、焦兒茶酸 (2-pyrocatechuic acid)、前列腺素E1 (prostaglandin E1)、甲硫胺酸 (methionine)、古羅糖酸內酯 (L-gulono-1,4-lactone)、乳酸 (lactate)等九種血清代謝物,及絲胺酸 (serine)、尿囊素 (allantoin)、甲基硫化腺&;#33527; (5''-methylthioadenosine)、牛磺酸 (taurine)等四種尿液代謝物。代謝體學分析結果顯示,這些代謝物可能與酒精性脂肪肝之生成及改善有相關性,可提供作為健康管理及臨床應用上之生物標記物 (biomarker)。

Fatty liver is highly associated with hepatic cirrhosis, and liver cancer. The pathogenesis of fatty liver is mainly divided into two categories: non-alcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD). Alcoholic and non-alcoholic fatty livers could be induced by alcohol consumption, obesity and hyperlipidemia. Ginger has been reported to exhibit antioxidant potential and hepatoprotective activity. In present study, a mouse model for AFLD was developed and validated by employing male C57BL/6 (B6) mice with alcohol containing liquid diet (Lieber-DeCarli diet) ad libitum. In the treatment groups, ginger essential oil (GEO) and citral, one of the major active compounds in GEO, were administered orally every day for 4 weeks. Metabolites in serum and urine samples were profiled by ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS). Serum biochemical analysis, liver antioxidant enzyme activity and histopathological evaluation, of GEO treated mice exhibited hepatoprotective activity on alcohol-induced fatty liver. Several metabolites involved in key biochemical pathways were identified to be implicated by AFLD after four weeks of alcohol administration, such as D-glucurono-6,3-lactone, glycerol-3-phosphate, pyruvic acid, lithocholic acid, 2-pyrocatechuic acid, prostaglandin E1, methionine, L-gulono-1,4-lactone, lactate in serum samples, and serine, allantoin, 5''-methylthioadenosine, taurine in urine samples. The metabolomics result indicated these metabolites were related to AFLD. These metabolites can be use as biomarker candidates for the healthy management and clinical application on AFLD.

中文摘要……………………………………………………………………………… I
Abstract..………………………………………………………………………...…… II
目錄…………………………………………………………………………………. III
圖目錄.......................................................................................................................... V
表目錄...................................................................................................................... VIII
附錄目錄..................................................................................................................... IX
縮寫表.......................................................................................................................... X
第一章 前言………………………………..……………………………...………… 1
第二章 文獻回顧………………………………………………………….………… 2
第一節 肝臟....………………………………………………………..……....... 2
第二節 酒精性脂肪肝.......................………………………….............…......... 7
第三節 薑……………………………………………………..……................. 13
第四節 代謝體學…………………………....……………………..…..……... 18
第三章 研究目的與實驗架構..................…………………………………………. 24
第一節 研究假說………………………………………………...…..…..….... 24
第二節 研究目的............................................................................................... 24
第三節 實驗架構………………………………………………....…………... 24
第四章 實驗材料與方法……………..…………………………...……………….. 28
第一節 實驗材料....................………………………………………….…….. 28
第二節 實驗藥品……………………………………………………..…...….. 28
第三節 儀器設備………………………………………………………..…..... 29
第四節 實驗動物....................………………………………………….…….. 29
第五節 實驗方法………………………………………………………..…..... 31
第五章 實驗結果與討論....................…………………………………………..…. 41
第一節 第一部分-評估酒精液態飼料誘導小鼠酒精性脂肪肝之程度.......... 41
第二節 第二部分-評估薑精油抗酒精性脂肪肝之功效.................................. 50
第三節 第三部分-以代謝體學分析薑精油抗酒精性脂肪肝之生物標記物及途徑..................................................................................................... 70
第六章 結論........………………………………………………........……………... 89
第七章 參考文獻…………………………..………………………………………. 90
第八章 附錄………………………………………..…………………......……..... 104


行政院衛生署統計室。2012。中華民國一○○年死因統計。
行政院衛生福利部統計室。2013。中華民國一○一年死因統計。
行政院衛生福利部統計室。2014。中華民國一○二年死因統計。
朱嘉琳。2007。薑心比心:薑療.薑食.生薑妙用小典。麥田出版社。P. 56&;#8722;85。
沈立言、林淑媛、蔡順仁。1992。以氣相層析儀嗅聞法進行蒜及薑精油揮發性成分香氣之評估。中國農業化學雜誌。30。P. 14&;#8722;24。
呂孟芳。2002。生薑.減肥.治百病。安立出版社。P. 26&;#8722;56。
林宗旦,林宗平,林景彬。1996。中藥藥理學。華香園出版社。P. 33&;#8722;37。
林宜信。2002。認識常用中藥 (一)。行政院衛生署中醫藥委員會。P. 58&;#8722;60。
紀瑋婷。2009。用乙醯胺基苯酚誘導慢性肝炎損傷之動物模式探討薑精油與薑乙醇萃取物之護肝功效。國立臺灣大學食品科技研究所碩士論文。
荷莉.費努。2008。藥草療效全書。城邦文化事業股份有限公司。P. 176&;#8722;183。
陳嘉琳。2004。薑精油對肝癌細胞及正常肝細胞生理機能之影響。國立臺灣大學食品科技研究所碩士論文。
黃毅。2002。百草藥譜-根.根莖篇。泛亞國際文化科技股份有限公司。P. 59&;#8722;61。
溫佑君、Ruth von Braunschweig。2003。精油圖鑑。城邦文化事業股份有限公司。P. 176。
蘇婧。2008。薑。八方出版社。P. 4&;#8722;87。
Afzal, M.; Al-Hadidi, D.; Menon, M.; Pesek, J.; Dhami, M. S. Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol. Drug Interact. 2001, 18, 159&;#8722;190.
Ahmed, M. H. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The need for biochemical markers. Scand. J. Gastroenterol. 2006, 41, 372.
Ahmed, R. S.; Seth, V.; Banerjee, B. D. Influence of dietary ginger (Zingiber officinales Rosc.) on antioxidant defense system in rat: comparison with ascorbic acid. Indian J. Exp. Biol. 2000, 38, 604&;#8722;606.
Ahmed, R. S.; Suke, S. G.; Seth, V.; Chakrahorti, A.; Tripathi, A. K.; Banerjee, B. D. Protective effects of dietary ginger (Zingiber officinales Rosc.) on lindane-induced oxidative stress in rats. Phytother. Res. 2008, 22, 902&;#8722;906.
Ajith, T. A.; Hema, U.; Aswathy, M. S. Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status. Food Chem. Toxicol. 2007, 45, 2267&;#8722;2272.
Akoachere, J. F.; Ndip, R. N.; Chenwi, E. B.; Ndip, L. M.; Njock, T. E.; Anong, D. N. Antibacterial effect of Zingiber officinale and Garcinia kola on respiratory tract pathogens. East Afr. Med. J. 2002, 79, 588&;#8722;592.
Al-Amin, Z. M.; Thomson, M.; Al-Qattan, K. K.; Peltonen-Shalaby, R.; Ali, M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br. J. Nutr. 2006, 96, 660&;#8722;666.
Albano, E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 2006, 65, 278&;#8722;290.
Ali, B. H.; Blunden, G.; Tanira, M. O.; Nemmar, A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem. Toxicol. 2008, 46, 409&;#8722;420.
Allen, J.; Davey, H. M.; Broadhurst, D.; Heald, J. K.; Rowland, J. J.; Oliver, S. G.; Kell, D. B. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol. 2003, 21, 692&;#8722;696.
Amin, A.; Hamza, A. A. Effects of roselle and ginger on cisplatin-induced reproductive toxicity in rats. Asian J. Androl. 2006, 8, 607&;#8722;612.
An, J.; Muoio, D. M.; Shiota, M.; Fujimoto, Y.; Cline, G. W.; Shulman, G. I.; Koves, T. R.; Stevens, R.; Millington, D.; Newgard, C. B. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 2004, 10, 268&;#8722;274.
Back, P.; Schernau-Potzi, L. Effect of ethanol on the metabolism of lithocholic acid in rat liver. N.-S. Arch. Pharmacol. 1972, 275, 135&;#8722;145.
Bakker, J.; Gris, P.; Coffernils, M.; Kahn, R. J.; Vincent, J. L. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am. J. Surg. 1996, 171, 221&;#8722;226.
Beecher, C. W. W. The human metabolome. Chap. 17. Kluwer Academic Publishers. Boston, Massachusetts, USA. 2003, 311–319.
Bhandari, U.; Kanojia, R.; Pillai, K. K. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J. Ethnopharmacol. 2005, 97, 227&;#8722;230.
Bhat, G.; Baba, C. S.; Pandey, A.; Kumari, N.; Choudhuri, G. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J. Hepatol. 2012, 4, 209&;#8722;217.
Bleyman, M. A.; Thurman, R. G. Comparison of acute and chronic ethanol administration on rates of ethanol elimination in the rat in vivo. Biochem. Pharmacol. 1979, 28, 2027&;#8722;2030.
Block, T. M.; Mehta, A. S.; Fimmel, C. J.; Jordan, R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22, 5093&;#8722;5107.
Bouwens, L. Proliferation and phenotypic expression of non-parenchymal liver cells. Scand. J. Gastroenterol. Suppl. 1988, 151, 46&;#8722;51.
Bradford, B. U.; O''Connell, T. M.; Han, J.; Kosyk, O.; Shymonyak, S.; Ross, P. K.; Winnike, J.; Kono, H.; Rusyn, I. Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol. App. Pharmacol. 2008, 232, 236&;#8722;243.
Bucolo, G.; David, H. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 1973, 19, 476&;#8722;482.
Carlberg, I.; Mannervik, B. Glutathione reductase. Methods Enzymol. 1985, 113, 484&;#8722;490.
Caro, A. A.; Cederbaum, A. I. Antioxidant properties of S-adenosyl-L-methionine in Fe2+-initiated oxidations. Free Radic. Biol. Med. 2004, 36, 1303-1316.
Carson, E. J.; Pruett, S. B. Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol. Alcohol. Clin. Exp. Res. 1996, 20, 132&;#8722;138.
Charlier, C.; Michaux, C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur. J. Med. Chem. 2003, 38, 645&;#8722;659.
Chen, T.; Xie, G.; Wang, X.; Fan, J.; Qiu, Y.; Zheng, X.; Qi, X.; Cao, Y.; Su, M.; Wang, X.; Xu, L. X.; Yen, Y.; Liu, P.; Jia, W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol. Cell Proteomics. 2011, 10, M110.004945-1&;#8722;13.
Chung, W. Y.; Jung, Y. J.; Surh, Y. J.; Lee, S. S.; Park, K. K. Antioxidative and antitumor promoting effects of [6]-paradol and its homologs. Mutat. Res. 2001, 496, 199&;#8722;206.
Corthesy-Theulaz, I.; den Dunnen, J. T.; Ferre, P.; Geurts, J. M. W.; Muller, M.; van Belzen, N.; van Ommen, B. Nutrigenomics: the impact of biomics technology on nutrition research. Ann. Nutr. Metab. 2005, 49, 355&;#8722;365.
Crabb, D. W. Recent developments in alcoholism: the liver. Recent Dev. Alcohol. 1993, 11, 207&;#8722;230.
Dahle, M. K.; Myhre, A. E.; Aasen, A. O.; Wang, J. E. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9. Infect. Immun. 2005, 73, 7290&;#8722;7296.
Day, C. P.; Yeaman, S. J. The biochemistry of alcohol-induced fatty liver. Biochim. Biophys. Acta. 1994, 1215, 33&;#8722;48.
Devi, S. L.; Anuradha, C. V. Oxidative and nitrosative stress in experimental rat liver fibrosis: Protective effect of taurine. Environ. Toxicol. Pharmacol. 2010, 29, 104&;#8722;110.
Donohue, T. M. Jr. Alcohol-induced steatosis in liver cells. World J. Gastroenterol. 2007, 13, 4974&;#8722;4978.
Duhamel, R. C.; Meezan, E.; Brendel, K. The addition of SDS to the Bradford dye-binding protein assay, a modification with increased sensitivity to collagen. J. Biochem. Biophys. Methods. 1981, 5, 67&;#8722;74.
Dunn, W. B.; Broadhurst, D. I.; Atherton, H. J.; Goodacre, R.; Griffin, J. L. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 2011, 40, 387&;#8722;426.
Enzan, H.; Himeno, H.; Hiroi, M.; Kiyoku, H.; Saibara, T.; Onishi, S. Development of hepatic sinusoidal structure with special reference to the Ito cells. Microsc. Res. Tech. 1997, 39, 336&;#8722;349
Eyer, P.; Podhradsky, D. Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman’s reagent. Anal. Biochem. 1986, 153, 57&;#8722;66.
Fiehn, O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp. Funct. Genom. 2001, 2, 155&;#8722;168.
Fiehn, O. Metabolomics-the link between genotypes and phenotypes. Plant. Mol. Biol. 2002, 48, 155&;#8722;171.
Fischer-Rasmussen, W.; Kjaer, S. K.; Dahl, C.; Asping, U. Ginger treatment of hyperemesis gravidarum. Eur. J. Obstet. Gynecol. Reprod. Biol. 1991, 38, 19&;#8722;24.
Fon Tacer, K.; Rozman D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipid. 2011, doi: 10.1155/2011/783976, 1&;#8722;14.
French, S. W. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J. Biomed. Sci. 2001, 8, 20&;#8722;27.
Friedman, S. L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275, 2247&;#8722;2250.
Fuhrman, B.; Rosenblat, M.; Hayek, T.; Coleman, R.; Aviram, M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutr. 2000, 130, 1124&;#8722;1131.
Garcia-Canaveras, J. C.; Donato, M. T.; Castell, J. V.; Lahoz, A. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J. Proteome Res. 2011, 10, 4825&;#8722;4834.
Ghayur, M. N.; Gilani, A. H.; Afridi, M. B.; Houghton, P. J. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul. Pharmacol. 2005, 43, 234&;#8722;241.
Gibney, M. J.; Walsh, M.; Brennan, L.; Roche, H. M.; German, B.; van Ommen, B. Metabolomics in human nutrition: opportunities and challenges. Am. J. Clin. Nutr. 2005, 82, 497&;#8722;503.
Gong, F.; Fung, Y. S.; Liang, Y. Z. Determination of volatile components in ginger using gas chromatography-mass spectrometry with resolution improved by data processing techniques. J. Agric. Food Chem. 2004, 52, 6378&;#8722;6383.
Goyal, R. K.; Kadnur, S. V. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006, 77, 160&;#8722;163.
Grieco, A.; Forgione, A.; Miele, L.; Vero, V.; Greco, A. V.; Gasbarrini, A.; Gasbarrini, G. Fatty liver and drugs. Eur. Rev. Med. Pharmacol. Sci. 2005, 9, 261&;#8722;263.
Grzanna, R.; Lindmark, L.; Frondoza, C. G. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food 2005, 8, 125&;#8722;132.
Gyamfi, M. A.; Wan, Y. Y. Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Exp. Biol. Med. 2010, 235, 547&;#8722;560.
Habib, H. M.; Makpol, S.; Hamid, N. A.; Das, S.; Zurinah, W.; Ngah, W.; Yusof, Y. A. M. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008, 63, 807–813.
Haksar, A.; Sharma, A.; Chawla, R.; Kumar, R.; Arora, R.; Singh, S.; Prasad, J.; Gupta, M.; Tripathi, R. P.; Arora, M. P.; Islam, F.; Sharma, R. K. Zingiber officinale exhibits behavioral radioprotection against radiation-induced CTA in a gender-specific manner. Pharmacol. Biochem. Behav. 2006, 84, 179&;#8722;188.
Hall, de la M. P.; Lieber, C. S.; DeCarli, L. M.; French, S. W.; Lindros, K. O.; Jarvelainen, H.; Bode, C.; Parlesak, A.; Bode, J. C. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol. Clin. Exp. Res. 2001, 25, 254S&;#8722;261S.
Haque, M. F.; Aghabeighi, B.; Wasil, M.; Hodges, S.; Harris, M. Oxygen free radicals in idiopathic facial pain. Bangladesh Med. Res. Counc. Bull. 1994, 20, 104&;#8722;116.
Hardison, W. G.; Tomaszewski, N.; Grundy, S. M. Effect of acute alterations in small bowel transit time upon the biliary excretion rate of bile acids. Gastroenterology 1979, 76, 568&;#8722;574.
He, W.; Miao, F. J.; Lin, D. C.; Schwandner, R. T.; Wang, Z.; Gao, J.; Chen, J. L.; Tian, H.; Ling, L. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004, 429, 188&;#8722;193.
Heeba, G. H.; Abd-Elghany, M. I. Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats. Phytomedicine 2010, 17, 1076&;#8722;1081.
Higuchi, H.; Gores, G. J. Mechanisms of liver injury: an overview. Curr. Mol. Med. 2003, 3, 483&;#8722;490.
Hoek, J. B.; Pastorino, J. G. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002, 27, 63&;#8722;68.
Hoyumpa, A. M.; Greene, H. L.; Dunn, G. D.; Schenker, S. Fatty liver: biochemical and clinical considerations. Am. J. Dig. Dis. 1975, 20, 1142&;#8722;1170.
Hsieh, Y. L.; Yeh, Y. H.; Lee, Y. T.; Huang, C. Y. Effect of taurine in chronic alcoholic patients. Food Funct. 2014, 5, 1529&;#8722;1535.
Ippoushi, K.; Azuma, K.; Ito, H.; Horie, H.; Higashio, H. [6]-Gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reactions. Life Sci. 2003, 73, 3427&;#8722;3437.
Iredale, J. P. Cirrhosis: new research provides a basis for rational and targeted treatments. Br. Med. J. 2003, 327, 143&;#8722;147.
Jaeschke, H. Reactive oxygen and mechanisms of inflammatory liver injury. J. Gastroenterol. Hepatol. 2000, 15, 718&;#8722;724.
Jagetia, G. C.; Baliga, M. S.; Venkatesh, P.; Ulloor, J. N. Influence of ginger rhizome (Zingiber officinale Rosc.) on survival, glutathione and lipid peroxidation in mice after whole-body exposure to gamma radiation. Radiat. Res. 2003, 160, 584&;#8722;592.
Jesenberger, V.; Jentsch, S. Deadly encounter: ubiquitin meets apoptosis. Nat. Rev. Mol. Cell Biol. 2002, 3, 112&;#8722;121.
Ji, S.; Lemasters, J. J.; Christenson, V.; Thurman, R. G. Periportal and pericentral pyridine nucleotide fluorescence from the surface of the perfused liver: evaluation of the hypothesis that chronic treatment with ethanol produces pericentral hypoxia. Proc. Natl. Acad. Sci. U. S. A. 1982, 79, 5415&;#8722;5419.
Johansson, L. H.; Borg, L. A. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem. 1988, 174, 331&;#8722;336.
Jolad, S. D.; Lantz, R. C.; Solyom, A. M.; Chen, G. J.; Bates, R. B.; Timmermann, B. N. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry 2004, 65, 1937&;#8722;1954.
Kadnur, S. V.; Goyal, R. K. Beneficial effects of Zingiber officinale Roscoe on fructose induced hyperlipidemia and hyperinsulinemia in rats. Indian. J. Exp. Biol. 2005, 43, 1161&;#8722;1164.
Kalhan, S. C.; Guo, L.; Edmison, J.; Dasarathy, S.; McCullough, A. J.; Hanson, R. W.; Milburn, M. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism. 2011, 60, 404&;#8722;413.
Katiyar, S. K.; Agarwal, R.; Mukhtar, H. Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer. Res. 1996, 56, 1023&;#8722;1030.
Kato, S.; Kawase, T.; Alderman, J.; Inatomi, N.; Lieber, C. S. Role of xanthine oxidase in ethanol-induced lipid peroxidation in rats. Gastroenterology 1990, 98, 203&;#8722;210.
Keriai, M. D. J.; Waterfield, C. J.; Kenyon, S. H.; Asker, D. S.; Timbrell, J. A. Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats. Amino Acids. 1998, 15, 53–76.
Kersten, S.; Seydoux, J.; Peters, J. M.; Gonzalez, F. J.; Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103, 1489&;#8722;1498.
Kim, J. K.; Kim, Y.; Na, K. M.; Surh, Y. J.; Kim, T. Y. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic. Res. 2007, 41, 603&;#8722;614.
Kind, T.; Tolstikov, V.; Fiehn, O.; Weiss, R. H. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal. Biochem. 2007, 363, 185&;#8722;195.
Kiuchi, F.; Iwakami, S.; Shibuya, M.; Hanaoka, F.; Sankawa, U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem. Pharm. Bull. 1992, 40, 387&;#8722;391.
Kiuchi, F.; Shibuya, M.; Sankawa, U. Inhibitors of prostaglandin biosynthesis from ginger. Chem. Pharm. Bull. 1982, 30, 754&;#8722;757.
Koo, K. L.; Ammit, A. J.; Tran, V. H.; Duke, C. C.; Roufogalis, B. D. Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thromb. Res. 2001, 103, 387&;#8722;397.
Krysko, D. V.; Vanden Berghe, T.; D''Herde, K.; Vandenabeele, P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 2008, 44, 205&;#8722;221.
Kuo, J. M.; Yeh, D. B.; Pan, B. S. Rapid photometric assay evaluating antioxidative activity in edible plant material. J. Agric. Food Chem. 1999, 47, 3206&;#8722;3209.
Kussmann, M.; Rezzi, S.; Daniel, H. Profiling techniques in nutrition and health research. Curr. Opin. Biotechnol. 2008, 19, 83&;#8722;99.
Lewis, G. D.; Wei, R.; Liu, E.; Yang, E.; Shi, X.; Martinovic, M.; Farrell, L.; Asnani, A.; Cyrille, M.; Ramanathan, A.; Shaham, O.; Berriz, G.; Lowry, P. A.; Palacios, I. F.; Tasan, M.; Roth, F. P.; Min, J.; Baumgartner, C.; Keshishian, H.; Addona, T.; Mootha, V. K.; Rosenzweig, A.; Carr, S. A.; Fifer, M. A.; Sabatine, M. S.; Gerszten, R. E. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J. Clin. Invest. 2008, 118, 3503&;#8722;3512.
Lieber, C. S. Effect of ethanol upon lipid metabolism. Lipids 1974, 9, 103&;#8722;116.
Lieber, C. S. Medical and nutritional complications of alcoholism: mechanisms and management. New York: Plenum Press. 1992.
Lieber, C. S. Alcohol and the liver: 1994 update. Gastroenterology 1994, 106, 1085&;#8722;1105.
Lieber, C. S. Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment. J. Stud. Alcohol. 1998, 59, 9&;#8722;25.
Lieber, C. S. S-adenosyl-L-methionine: its role in the treatment of liver disorders. AM. J. Clin. Nutr. 2002, 76, 1183–1187.
Lieber, C. S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34, 9&;#8722;19.
Lieber, C. S. Metabolism of alcohol. Clin. Liver Dis. 2005, 9, 1&;#8722;35.
Lieber, C. S. Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years. Rocz. Akad. Med. Bialymst. 2005, 50, 7&;#8722;20.
Lieber, C. S.; DeCarli, L. M. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol. Clin. Exp. Res. 1982, 6, 523&;#8722;531.
Lieber, C. S.; DeCarli, L. M. Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol. 1989, 24, 197&;#8722;211.
Lieber, C. S.; Jones, D. P.; DeCarii, L. M. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J. Clin. Invest. 1965, 44, 1009&;#8722;1021.
Lin, S. C.; Lin, Y. H.; Chen, C. F.; Chung, C. Y.; Hsu, S. H. The hepatoprotective and therapeutic effects of propolis ethanol extract on chronic alcohol-induced liver injuries. Am. J. Chin. Med. 1997, 25, 325&;#8722;332.
Liu, C. J.; Jeng, Y. M.; Chen, P. J.; Lai, M. Y.; Yang, H. C.; Huang, W. L.; Kao, J. H.; Chen, D. S. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty disease in chronic hepatitis C. Antivir. Ther. 2005, 10, 405&;#8722;415.
Lu, P.; Lai, B. S.; Liang, P.; Chen, Z. T.; Shun, S. Q. Antioxidation activity and protective effection of ginger oil on DNA damage in vitro. Zhongguo Zhong Yao Za Zhi 2003, 28, 873&;#8722;875.
Mahady, G. B.; Pendland, S. L.; Yun, G. S.; Lu, Z. Z.; Stoia, A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res. 2003, 23, 3699&;#8722;3702.
Mallikarjuna, K.; Sahitya Chetan, P.; Sathyavelu Reddy, K.; Rajendra, W. Ethanol toxicity: rehabilitation of hepatic antioxidant defense system with dietary ginger. Fitoterapia. 2008, 79, 174&;#8722;178.
Mansouri, A.; Gaou, I.; de Kerguenec, C.; Amsellem, S.; Haouzi, D.; Berson, A.; Moreau, A.; Feldmann, G.; Letteron, P.; Pessayre, D.; Fromenty, B. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999, 117, 181&;#8722;190.
Manna, S. K.; Patterson, A. D.; Yang, Q.; Krausz, K. W.; Idle, J. R.; Fornace, A. J.; Gonzalez, F. J. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J. Proteome Res. 2011, 10, 4120&;#8722;4133.
Marklund, S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta. Physiol. Scand. Suppl. 1980, 492, 19&;#8722;23.
Martel-Pelletier, J.; Lajeunesse, D.; Reboul, P.; Pelletier, J. P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann. Rheum. Dis. 2003, 62, 501&;#8722;509.
Mascolo, N.; Jain, R.; Jain, S. C.; Capasso, F. Ethnopharmacologic investigation of ginger (Zingiber officinale). J. Ethnopharmacol. 1989, 27, 129&;#8722;140.
Masson, S.; Desmoulin, F.; Sciaky, M.; Cozzone, P. J. Catabolism of adenine nucleotides and its relation with intracellular phosphorylated metabolite concentration during ethanol oxidation in perfused rat liver. Biochemistry 1993, 32, 1025&;#8722;1031.
Mates, J. M.; Perez-Gomez, C.; Nunez de Castro, I. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32, 595&;#8722;603.
Meister, A.; Anderson, M. E. Glutathione. Annu. Rev. Biochem. 1983, 52, 711&;#8722;760.
Nagasawa, H.; Watanabe, K; Inatomi, H. Effects of bitter melon (Momordica charantia L.) or ginger rhizome (Zingiber offifinale Rosc.) on spontaneous mammary tumorigenesis in SHN mice. Am. J. Chin. Med. 2002, 30, 195&;#8722;205.
Nanji, A. A. Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004, 34, 21&;#8722;25.
Nicholson, J. K.; Lindon, J. C. Systems biology: Metabonomics. Nature 2008, 455, 1054&;#8722;1056.
Nicholson, J. K.; Wilson, I. D. Opinion: understanding ''global'' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2003, 2, 668&;#8722;676.
Norajit, K.; Laohakunjit, N.; Kerdchoechuen, O. Antibacterial effect of five Zingiberaceae essential oils. Molecules 2007, 12, 2047&;#8722;2060.
Nosadini, R.; Ursini, F.; Tessari, P.; Giengo, A.; Gregolin, C. Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon. Horm. Metab. Res. 1979, 11, 661&;#8722;664.
Ojewole, J. A. Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother. Res. 2006, 20, 764&;#8722;772.
Oresic, M. Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 816&;#8722;824.
Ozel, M. Z.; Kaymaz, H. Superheated water extraction, steam distillation and Soxhlet extraction of essential oils of Origanum onites. Anal. Bioanal. Chem. 2004, 379, 1127&;#8722;1133.
Paglia, D. E.; Valentine, W. N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70, 158&;#8722;169.
Park, K. K.; Chun, K. S.; Lee, J. M.; Lee, S. S.; Surh, Y. J. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 1998, 129, 139&;#8722;144.
Phaneuf, H. Herbs demystified: a scientist explains how the most common herbal remedies really work. Perseus Books Group. 2005. ISBN-13: 9781569244081.
Phillips, S.; Ruggier, R.; Hutchinson, S. E. Zingiber officinale (ginger)-an antiemetic for day case surgery. Anaesthesia 1993, 48, 715&;#8722;717.
Pineiro-Carrero, V. M.; Pineiro, E. O. Liver. Pediatrics. 2004, 113, 1097&;#8722;1106.
Raamsdonk, L. M.; Teusink, B.; Broadhurst, D.; Zhang, N.; Hayes, A.; Walsh, M. C.; Berden, J. A.; Brindle, K. M.; Kell, D. B.; Rowland, J. J.; Westerhoff, H. V.; van Dam, K.; Oliver, S. G. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 2001, 19, 45&;#8722;50.
Rasineni, K.; Casey, C. A. Molecular mechanism of alcoholic fatty liver. Indian J. Pharmacol. 2012, 44, 299&;#8722;303.
Reddy, A. C.; Lokesh, B. R. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol. Cell Biochem. 1992, 111, 117&;#8722;124.
Reuben, A. Ito becomes a star. Hepatology. 2002, 35, 503&;#8722;504.
Rezzi, S.; Ramadan, Z.; Fay, L. B.; Kochhar, S. Nutritional metabonomics: applications and perspectives. J. Proteome res. 2007, 6, 513&;#8722;525.
Rigato, I.; Cravatari, M.; Avellini, C.; Ponte, E.; Croce, S. L.; Tiribelli, C. Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007, 4, 403&;#8722;408.
Ryan, D.; Robards, K. Metabolomics: The greatest omics of them all? Anal. Chem. 2006, 78, 7954&;#8722;7958.
Shackelford, C.; Long, G.; Wolf, J.; Okerberg, C.; Herbert, R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol. Pathol. 2002, 30, 93&;#8722;96.
Sharma, S. S.; Gupta, Y. K. Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber officinale). J. Ethnopharmacol. 1998, 62, 49&;#8722;55.
Sharma, S. S.; Kochupillai, V.; Gupta, S. K.; Seth, S. D.; Gupta, Y. K. Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs. J. Ethnopharmacol. 1997, 57, 93&;#8722;96.
Shin, H. K.; Linkswiler, H. M. Tryptophan and methionine metabolism of adult females as affected by vitamin B-6 deficiency. J. Nutr. 1974, 104, 1348–1355.
Shukla, Y.; Singh, M. Cancer preventive properties of ginger: a brief review. Food Chem. Toxicol. 2007, 45, 683&;#8722;690.
Siddaraju, M. N.; Dharmesh, S. M. Inhibition of gastric H+, K+-ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale. Mol. Nutr. Food Res. 2007, 51, 324&;#8722;332.
Singh, G.; Kapoor, I. P.; Singh, P.; de Heluani, C. S.; de Lampasona, M. P.; Catalan, C. A. Chemistry, antioxidant and antimicrobial investigations on essential oil and oleoresins of Zingiber officinale. Food Chem. Toxicol. 2008, 46, 3295&;#8722;3302.
Sozio, M.; Crabb, D. W. Alcohol and lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E10&;#8722;E16.
Srivas, K. C. Effects of aqueous extracts of onion, garlic and ginger on platelet aggregation and metabolism of arachidonic acid in the blood vascular system: in vitro study. Prostaglandins. Leukot. Med. 1984, 13, 227&;#8722;235.
Stewart, J. J.; Wood, M. J.; Wood, C. D.; Mims, M. E. Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology 1991, 42, 111&;#8722;120.
Stoilova, I.; Krastanov, A.; Stoyanova, A.; Denev, P.; Gargova, S. Antioxidant activity of a ginger extract (Zingiber officinale). Food chem. 2007, 102, 764&;#8722;770.
Sturgill, M. G.; Lambert, G. H. Xenobiotic-induced hepatotoxicity: mechanism of liver injury and methods of monitoring hepatic function. Clin. Chem. 1997, 43, 1512&;#8722;1526.
Suekawa, M.; Aburada, M.; Hosoya, E. Pharmacological studies on ginger. II. Pressor action of (6)-shogaol in anesthetized rats, or hindquarters, tail and mesenteric vascular beds of rats. J. Pharmacobiodyn. 1986, 9, 842&;#8722;852.
Sul, H. S.; Wang, D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu. Rev. Nutr. 1998, 18, 331&;#8722;351.
Surh, Y. J. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 2002, 40, 1091&;#8722;1097.
Syn, W. K.; Teaberry, V.; Choi, S. S.; Diehl, A. M. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin. Liver Dis. 2009, 29, 200&;#8722;210.
Tessari, P.; Meneghel, A.; Avogaro, A.; Duner, E.; Del Prato, S.; Tuzzato, M.; Tiengo, A. Glycerophosphate acetyltransferase activity in perfused liver of normal and hyperlipemic rats: glucagon effect. Acta. Diabetol. Lat. 1981, 18, 357&;#8722;363.
Thomson, M.; Al-Qattan, K. K.; Al-Sawan, S. M.; Alnaqeeb, M. A.; Khan, I.; Ali, M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins. Leukot. Essent. Fatty Acids. 2002, 67, 475&;#8722;478.
Thurman, R. G.; Bradford, B. U.; Iimuro, Y.; Knecht, K. T.; Arteel, G. E.; Yin, M.; Connor, H. D.; Wall, C.; Raleigh, J. A.; Frankenberg, M. V.; Adachi, Y.; Forman, D. T.; Brenner, D.; Kadiiska, M.; Mason, R. P. The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J. Gastroenterol. Hepatol. 1998, 13, S39&;#8722;S50.
Trujillo, E.; Davis, C.; Milner, J. Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. J. Am. Diet. Assoc. 2006, 106, 403&;#8722;413.
Tsukamoto, H.; Horne, W.; Kamimura, S.; Niemela, O.; Parkkila, S.; Yla-Herttuala, S.; Brittenham, G. M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 1995, 96, 620&;#8722;630.
Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M. T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44&;#8722;84.
van der Werf, M. J.; Jellema, R. H.; Hankemeier, T. Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets. J. Ind. Microbiol. Biotechnol. 2005, 32, 234-52.
Vinaixa, M.; Rodriguez, M. A.; Rull, A.; Beltran, R.; Blade, C.; Brezmes, J.; Canellas, N.; Joven, J.; Correig, X. Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J. Proteome Res. 2010, 9, 2527&;#8722;2538.
Wan, L.; Tsai, C. H.; Tsai, Y.; Hsu, C. M.; Lee, C. C.; Tsai, F. J. Mutation analysis of Taiwanese Wilson disease patients. Biochem. Biophys. Res. Commun. 2006, 354, 734&;#8722;738.
Waterfield, C. J.; Turton, J. A.; Scales, M. D.; Timbrell, J. A. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Arch. Toxicol. 1993, 67, 244&;#8722;254.
Wohlmuth, H.; Smith, M. K.; Brooks, L. O.; Myers, S. P.; Leach, D. N. Essential oil composition of diploid and tetraploid clones of ginger (Zingiber officinale Roscoe) grown in Australia. J. Agric. Food Chem. 2006, 54, 1414&;#8722;1419.
Wu, G.; Yang, J.; Sun, C.; Luan, X.; Shi, J.; Hu, J. Effect of taurine on alcoholic liver disease in rats. Amino Acids. 2009, 36, 457&;#8722;464.
Wu, H.; Ye, D.; Bai, Y.; Zhao, Y. Effect of dry ginger and roasted ginger on experimental gastric ulcers in rats. Zhongguo Zhong Yao Za Zhi 1990, 15, 278&;#8722;280, 317&;#8722;318.
Yamahara, J.; Mochizuki, M.; Rong, H. Q.; Matsuda, H.; Fujimura, H. The anti-ulcer effect in rats of ginger constituents. J. Ethnopharmacol. 1988, 23, 299&;#8722;304.
Yemitan, O. K.; Izegbu, M. C. Protective effects of Zingiber officinale (Zingiberaceae) against carbon tetrachloride and acetaminophen-induced hepatotoxicity in rats. Phytother. Res. 2006, 20, 997&;#8722;1002.
Young, H. Y.; Luo, Y. L.; Cheng, H. Y.; Hsieh, W. C.; Liao, J. C.; Peng, W. H. Analgesic and anti-inflammatory activities of [6]-gingerol. J. Ethnopharmacol. 2005, 96, 207&;#8722;210.
Zhou, H. L.; Deng, Y. M.; Xie, Q. M. The modulatory effects of the volatile oil of ginger on the cellular immune response in vitro and in vivo in mice. J. Ethnopharmacol. 2006, 105, 301&;#8722;305.


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊
 
系統版面圖檔 系統版面圖檔